Phibro Animal Health Corp (PAHC) stock
Close on Nov 13, 2026Market cap $1.46BP/E 14.3Yield 1.33%
Phibro Animal Health Corp grew revenue 10.1% to $1.54B over the twelve months to Sep 30, 2026. Operating income rose 33.8% to $192.78M, moving the operating margin from 10.3% to 12.5%. Free cash flow was $21.67M, down 36.8% from a year earlier. At the latest close the market valued the company at $1.46B, 14.3 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $1.46B
- P/E ratio
- 14.3
- Price to sales
- 0.95
- Price to book
- 3.50
- Dividend yield
- 1.33%
- Free cash flow yield
- 1.48%
Fundamentals
- Revenue
- $1.54B
- Net income
- $102.71M
- EPS, diluted
- $2.51
- Free cash flow
- $21.67M
- Book value per share
- $10.20
- Diluted shares
- 41M
Trading
- Next earnings
- Feb 3, 2027 (estimated, during market hours)
- Previous close
- $35.46
- Open
- $35.69
- Day's range
- $35.15 – $36.40
- Volume
- 293,913
- Average volume (20 days)
- 204,792
- Index membership
- S&P SmallCap 600, Russell 2000, Russell 3000
- Beta (5 years)
- 0.78
- 52-week range
- $28.25 – $60.08
- RSI (14 days)
- 46.5
- Volatility (1 year)
- 55.1%
- Relative volume
- 1.28×
- WACC
- 8.0%
On 1 of our idea list: Top scores
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2014, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | PAHC | S&P 500 | Difference | PAHC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -2.3% | -3.0% | +0.8 pts | ||
| 3 months | +5.9% | -2.8% | +8.7 pts | ||
| Year to date | -2.8% | +11.5% | −14.3 pts | ||
| 1 year | -18.5% | +13.5% | −32.0 pts | ||
| 3 years | +292.6% | +77.7% | +214.9 pts | +57.8% | +21.1% |
| 5 years | +79.0% | +72.6% | +6.4 pts | +12.4% | +11.5% |
| 10 years | +54.0% | +308.2% | −254.2 pts | +4.4% | +15.1% |
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Phibro Animal Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Results
- News
- Results
- News
About Phibro Animal Health
Pharmaceutical Preparations
Phibro Animal Health Corporation develops, manufactures, and sells animal health and mineral nutrition products, alongside specialty industrial chemicals. The business operates across three segments: Animal Health, Mineral Nutrition, and Performance Products. Offerings include antibacterials, anticoccidials, nutritional specialty products, vaccines, vaccine adjuvants, ethanol fermentation aids, fortifying mineral diets, and chemical catalyst ingredients. The company serves livestock producers, animal feed manufacturers, wholesalers, distributors, veterinarians, and industrial clients, targeting food animals such as poultry, cattle, and swine, as well as companion animals.
Company profile, executives and historyPhibro Animal Health stock: common questions
What is Phibro Animal Health's stock price?
PAHC closed at $35.97 on Nov 13, 2026, up 1.44% on the day. Over the past 52 weeks it traded between $28.25 and $60.08.
What is Phibro Animal Health's market cap?
Phibro Animal Health was worth $1.46B at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is PAHC's P/E ratio?
PAHC trades at 14.3 times earnings, based on diluted earnings per share of $2.51 over the twelve months to Sep 30, 2026.
How much revenue does Phibro Animal Health make?
Phibro Animal Health reported revenue of $1.54B for the twelve months to Sep 30, 2026, up 10.1% from a year earlier.
Does Phibro Animal Health pay a dividend?
Yes. Phibro Animal Health paid $0.48 per share over the last twelve months, a yield of 1.33% at the latest price.
When does Phibro Animal Health report earnings next?
Phibro Animal Health is expected to report Q2 FY2027 results on Feb 3, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has PAHC stock performed over the past year?
Including dividends, PAHC returned -18.5% over the past year, against +13.5% for the S&P 500.
How many PAHC shares are sold short?
1M shares were sold short at the latest FINRA report, 233.43% of the float, or 6.4 days of average trading volume.
Who are Phibro Animal Health's competitors?
Companies most similar to Phibro Animal Health by business, industry and size include ELAN, PBH, ZTS, ANIP, AMRX.
See a number that looks wrong?